A study for a 24 year old woman who takes Januvia, Invokana - from FDA reports
6 females aged 24 (±5) who take the same drugs are studied. This is a personalized study for a 24 year old female patient who has Type 2 Diabetes Mellitus. The study is created by eHealthMe based on reports from FDA.
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 19, 2017
6 females aged 24 (±5) who take Januvia, Invokana are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 24
- Gender: female
- Conditions: Type 2 Diabetes Mellitus
- Drugs taken:
- Januvia (sitagliptin phosphate)
- Invokana (canagliflozin)
eHealthMe real world results:
Comparison with this patient's adverse outcomes:
- Tinnitus: 0 (0% of females aged 24 (±5) who take the drugs)
As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
- Tinnitus in Type 2 Diabetes Mellitus: 0 (0% of females aged 24 (±5) who have Type 2 Diabetes Mellitus)
As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea
- Tinnitus in Januvia: 0 (0% of females aged 24 (±5) who take Januvia)
- Tinnitus in drugs with ingredients of Januvia: 0 (0% of females aged 24 (±5) who take drugs with ingredients of sitagliptin phosphate)
- Tinnitus in Invokana: 0 (0% of females aged 24 (±5) who take Invokana)
- Tinnitus in drugs with ingredients of Invokana: 0 (0% of females aged 24 (±5) who take drugs with ingredients of canagliflozin)
Most common drug interactions over time
< 1 month:n/a
1 - 6 months:n/a
6 - 12 months:n/a
1 - 2 years:
- diabetic ketoacidosis
2 - 5 years:n/a
5 - 10 years:n/a
- neuroleptic malignant syndrome
- social avoidant behavior
- muscle rigidity
- abnormal behavior
- high blood pressure
- pupillary reflex impaired
- injection site abscess
- gait disturbance
Top conditions involved for these people *:
- Preventive Health Care (2 people, 33.33%)
- Epilepsy (2 people, 33.33%)
- Birth Control (2 people, 33.33%)
- Aggression (2 people, 33.33%)
Top co-used drugs for these people *:
- Metformin (6 people, 100.00%)
- Paracetamol (2 people, 33.33%)
- Depo-Provera (2 people, 33.33%)
* Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Want to find out more about the FDA reports used in the study? You can request them from FDA.
Expand the study to include reports from both FDA and eHealthMeExpand this study to include FDA and eHealthMe reports
What are the drugs?
- Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. (latest outcomes from Januvia 42,434 users)
- Invokana has active ingredients of canagliflozin. It is often used in diabetes. (latest outcomes from Invokana 14,083 users)
What are the conditions?
- Type 2 diabetes mellitus can be treated by Metformin hydrochloride, Metformin, Januvia, Glipizide, Victoza (latest reports from 198,993 Type 2 diabetes mellitus patients)
What are the symtoms?
- Tinnitus (a ringing in the ears) has been reported by people with depression, high blood pressure, pain, osteoporosis, high blood cholesterol (latest reports from 31,645 Tinnitus patients).
Could your drugs cause:
Could your conditions cause:
Related publications that referenced our studies
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia®)", Dermatology online journal, 2012 Feb .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
Can you answer these questions?
Reaching out for support for individuals with same symptoms as myself...Since increasing Metoprolol I have started having ringing in the ears. And now I am experiencing optic eye pressure. According to research, if I can lose about 20-30 lbs and de-stress I may be able to reduce or do away ...
I have been using a good probiotic with digestive enzymes to help me with digestion and gas which seem to work fine- but now have terrible tinnitus in one ear- I also take a low dose anti depressive to sleep better called Seroquel- weening off that drug but tinnitus still bad- I guess I will ...
I have been on IV Vancomycin for two weeks now and I have frequent and urgent urination and woke up with ringing in my left ear this morning, it's driving me nuts. Does anyone know if this will go away or if I need to be concerned with these symptoms? I have four more weeks to go.
You may be interested in these posts
Wondering if anybody is suffering with low blood pressure after starting with januvia. I started getting dizzy and stayed dizzy all day. Confusion, dazed, unable to focus and just out of it. Dr. Took me off one medicine. Some improvement. Still get dizzy off and on. BP is around 150/68 sitting ...